Related references
Note: Only part of the references are listed.Evolutionary Innovations and Where to Find Them: Routes to Open-Ended Evolution in Natural and Artificial Systems
Tim Taylor
ARTIFICIAL LIFE (2019)
Towards an evolvable cancer treatment simulator
Richard J. Preen et al.
BIOSYSTEMS (2019)
A view on drug resistance in cancer
Neil Vasan et al.
NATURE (2019)
The 2019 mathematical oncology roadmap
Russell C. Rockne et al.
PHYSICAL BIOLOGY (2019)
PhysiCell: An open source physics-based cell simulator for 3-D multicellular systems
Ahmadreza Ghaffarizadeh et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
Rare cell variability and drug- induced reprogramming as a mode of cancer drug resistance
Sydney M. Shaffer et al.
NATURE (2017)
Two is better than one; toward a rational design of combinatorial therapy
Sheng-hong Chen et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2016)
Cancer stem cells and personalized cancer nanomedicine
Petra Gener et al.
NANOMEDICINE (2016)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm et al.
NATURE REVIEWS MATERIALS (2016)
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Andreas Wicki et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
Antonina V. Kurtova et al.
NATURE (2015)
Tackling the cancer stem cells - what challenges do they pose?
Diwakar R. Pattabiraman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
Hiroshi Maeda et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Challenges, expectations and limits for nanoparticles-based therapeutics in cancer: A focus on nano-albumin-bound drugs
Raphaelle Fanciullino et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors
Sabine Hauert et al.
NANO TODAY (2013)
Correction: Spartan: A Comprehensive Tool for Understanding Uncertainty in Simulations of Biological Systems
Kieran Alden et al.
PLoS Computational Biology (2013)
Evolutionary dynamics of cancer in response to targeted combination therapy
Ivana Bozic et al.
ELIFE (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
STEPS: efficient simulation of stochastic reaction-diffusion models in realistic morphologies
Iain Hepburn et al.
BMC SYSTEMS BIOLOGY (2012)
Techniques for grounding agent-based simulations in the real domain: a case study in experimental autoimmune encephalomyelitis
Mark Read et al.
MATHEMATICAL AND COMPUTER MODELLING OF DYNAMICAL SYSTEMS (2012)
Share Paper
